Bristol-Myers Squibb Company

BRM.DE·XETRA·Healthcare
Compare
56.08+1.82 (+3.35%)today
At close: Oct 22, 5:35 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close54.26
Open54.46
Day range54.4556.08
52-week range36.6061.19
Off day high0.00%
Off 52-week high−8.35%
Volume504
Avg. volume (3M)1.64K
Market cap114.56B
EPS (TTM)3.89
Forward P/E—
P/E ratio (TTM)14.42
Dividend yield4.11% (2.25)
Beta (5Y)0.18
Shares outstanding2.04B
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin18.87%

Against its peers

Compare in full ›
BRM.DE ABBV BIIB LLY AMGN GILD
Market cap 114.56B 503.11B 37.16B 1.16T 242.39B 194.52B
P/E (TTM) 14.4 80.4 44.7 43.8 27.8 —
Forward P/E — 17.6 15.3 27.7 18.3 15.7
Price/book 5.8 -84.8 2.0 34.4 20.7 16.5
Dividend yield 4.11% 2.43% — 0.54% 2.30% 2.14%
1-year change +43.81% +24.78% +60.57% +54.77% +49.66% +27.19%
Today +3.35% −0.03% +4.37% +2.76% +2.28% +2.16%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Bristol-Myers Squibb's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
AbbVie Inc.ABBV · Drug Manufacturers - General 503.11B 284.71 −0.03%
Biogen Inc.BIIB · Drug Manufacturers - General 37.16B 251.51 +4.37%
Eli Lilly and CompanyLLY · Drug Manufacturers - GeneralOdds 1.16T 1,305.83 +2.76%
Amgen Inc.AMGN · Drug Manufacturers - General 242.39B 448.35 +2.28%
Gilead Sciences, Inc.GILD · Drug Manufacturers - GeneralOdds 194.52B 156.88 +2.16%
Chugai Pharmaceutical Co., Ltd.CUP.F · Drug Manufacturers - General 61.41B 37.32 +2.64%
Pfizer Inc.PFE · Drug Manufacturers - GeneralOdds 172.47B 30.26 +1.37%
Recordati Industria Chimica e Farmaceutica S.p.A.REC.MI · Drug Manufacturers - General 11.01B 52.95 0.00%

Other companies in Drug Manufacturers - General, closest in size first.

Company Mkt cap Price Today
CSPC Pharmaceutical Group Limited1093.HK · Shijiazhuang, China 95.29B 8.355 −3.97%
GSK plcGSK · London, United Kingdom 102.74B 51.28 +2.52%
SanofiSNY · Paris, France 100.79B 42.07 +2.67%
Marksans Pharma LimitedMARKSANS.NS · Mumbai, India 133.43B 294.45 −1.24%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.600436.SS · Zhangzhou, China 73.31B 121.51 −0.71%
Pfizer Inc.PFE · New York, NYOdds 172.47B 30.26 +1.37%
Novo Nordisk A/SNVO · Bagsvaerd, Denmark 174.83B 39.62 +1.42%
Sichuan Kelun Pharmaceutical Co., Ltd.002422.SZ · Chengdu, China 68.02B 42.76 −0.77%

The stocks whose daily moves over the past year went most closely with Bristol-Myers Squibb's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
BRISTOL-MYERS SQUIBB CO.BRM.F · Correlation 0.76 114.29B 55.95 +2.59%
Pfizer Inc.PFE · Correlation 0.41Odds 172.47B 30.26 +1.37%
Amgen Inc.AMGN · Correlation 0.39 242.39B 448.35 +2.28%
Gilead Sciences, Inc.GILD · Correlation 0.36Odds 194.52B 156.88 +2.16%
Medtronic plc2M6.DE · Correlation 0.36 106.27B 83.08 −1.02%
AbbVie Inc.ABBV · Correlation 0.33 503.11B 284.71 −0.03%
Eli Lilly and CompanyLLY · Correlation 0.33Odds 1.16T 1,305.83 +2.76%

What visitors to Bristol-Myers Squibb's page also look at.

Company Mkt cap Price Today
BRISTOL-MYERS SQUIBB CO.BRM.F 114.29B 55.95 +2.59%
AMERICAN EXPRESS CO.AEC1.DE 193.75B 286.90 −0.59%
Ping An Insurance(Grp)Co.ChinaRPZX.F 99.23B 5.48 −1.44%
DEERE & CO.DCO.DE 151.04B 560.20 −0.92%
Ping An Insurance(Grp)Co.ChinaRPZXB.F 97.78B 10.80 −0.92%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All BRM.DE news ›
Seeking Alpha·Positive

Bristol-Myers Squibb: Why I'm Bullish Ahead Of Q3 Earnings

(NYSE:BMY) Seeking Alpha - On October 27, Bristol-Myers Squibb will report its results for Q3. - As a reminder, its Q2 revenue rose 12.9% quarter-on-quarter to $12.97 billion, primarily due to the strong performance of Camzyos and the…

The Motley Fool·Positive

AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue?

It completed the acquisition of Apogee Therapeutics to expand its dermatology and respiratory pipeline, and it secured regulatory approvals for multiple therapies in international markets. It secured accelerated regulatory approval for a…

Trefis·

What Is Going On With Bristol Myers Squibb Stock?

Bristol Myers Squibb (BMY) stock trades at 12.9 times earnings, compared with 22.7 for the median S&P 500 company. That is a low price for a drugmaker that widened its profit margin over the past year, even after the stock returned 41.6%…

TIKR.com·Positive

Better Dividend Stock: Merck vs. Bristol Myers Squibb

Pressmaster from Pressmaster and Ri_Ya from pixabay Merck (MRK) and Bristol Myers Squibb (BMY) both raised their 2026 sales outlooks this summer. That’s good news for income investors, since a growing business keeps a dividend growing. The…

From articles in the 4Search news index.

In the news

121mentions in 30 days
121with it in the headline
Mixedsentiment

Mentioned with

Bristol Myers Squibb116Bristol Myers104Pfizer97Johnson & Johnson76Eli Lilly73Astrazeneca51Astrazeneca Investors See Little Logic49Eli Lilly and Company46

People in the coverage

Bristol Myers106Eliquis78Revlimid71Abbvie68Brendan Coffey62Kim Johansen58

Themes

Bmy91Bristol Myers Squibb71Lly60Usmf-Health-Care56Jnj54Healthcare50Abbv41Stock Market35

Most coverage from

  1. theglobeandmail.com21
  2. marketscreener.com20
  3. marketbeat.com11
  4. fool.com10
  5. gurufocus.com8

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.